| Dr Mai Vy Hoang, OD | |
|
3408 Olsen Blvd, Amarillo, TX 79109 | |
| (806) 355-5633 | |
| (806) 355-9133 |
| Full Name | Dr Mai Vy Hoang |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 14 Years |
| Location | 3408 Olsen Blvd, Amarillo, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205148665 | NPI | - | NPPES |
| 83133Q | Other | TX | BCBS |
| 215984001 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 7599T (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Broome Professionals Pa | 0143495051 | 8 |
News Archive
Among the findings of an analysis of previous studies regarding ear infections in children are that results from otoscopic exams (an instrument for examining the interior of the ear) are critical to accurate diagnosis and antibiotics are modestly more effective than no treatment, with most antibiotics demonstrating similar rates of clinical success among children at normal risk, according to an article in the November 17 issue of JAMA.
Dynex Technologies, Inc. announced today it has finalized a supply agreement with TECHLAB, Inc. (Blacksburg, VA), allowing TECHLAB to utilize Dynex's Gold SmartKit packaging for their ELISA product line.
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.
A study by researchers at the University of Leicester has revealed new ways to spot whether medical research has hidden biases. Writing in the prestigious British Medical Journal, Santiago Moreno and his colleagues demonstrate how to spot 'publication bias' in the reporting of clinical trials which potentially form the basis of Government and NHS health policies.
AVEO Pharmaceuticals, Inc., today announced data from the final analysis of its Phase 2 randomized discontinuation trial evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with advanced renal cell carcinoma.
› Verified 9 days ago
| Provider Name | Broome Professionals Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952581670 PECOS PAC ID: 0143495051 Enrollment ID: O20111213000699 |
News Archive
Among the findings of an analysis of previous studies regarding ear infections in children are that results from otoscopic exams (an instrument for examining the interior of the ear) are critical to accurate diagnosis and antibiotics are modestly more effective than no treatment, with most antibiotics demonstrating similar rates of clinical success among children at normal risk, according to an article in the November 17 issue of JAMA.
Dynex Technologies, Inc. announced today it has finalized a supply agreement with TECHLAB, Inc. (Blacksburg, VA), allowing TECHLAB to utilize Dynex's Gold SmartKit packaging for their ELISA product line.
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.
A study by researchers at the University of Leicester has revealed new ways to spot whether medical research has hidden biases. Writing in the prestigious British Medical Journal, Santiago Moreno and his colleagues demonstrate how to spot 'publication bias' in the reporting of clinical trials which potentially form the basis of Government and NHS health policies.
AVEO Pharmaceuticals, Inc., today announced data from the final analysis of its Phase 2 randomized discontinuation trial evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with advanced renal cell carcinoma.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mai Vy Hoang, OD 3408 Olsen Blvd, Amarillo, TX 79109 Ph: (806) 355-5633 | Dr Mai Vy Hoang, OD 3408 Olsen Blvd, Amarillo, TX 79109 Ph: (806) 355-5633 |
News Archive
Among the findings of an analysis of previous studies regarding ear infections in children are that results from otoscopic exams (an instrument for examining the interior of the ear) are critical to accurate diagnosis and antibiotics are modestly more effective than no treatment, with most antibiotics demonstrating similar rates of clinical success among children at normal risk, according to an article in the November 17 issue of JAMA.
Dynex Technologies, Inc. announced today it has finalized a supply agreement with TECHLAB, Inc. (Blacksburg, VA), allowing TECHLAB to utilize Dynex's Gold SmartKit packaging for their ELISA product line.
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.
A study by researchers at the University of Leicester has revealed new ways to spot whether medical research has hidden biases. Writing in the prestigious British Medical Journal, Santiago Moreno and his colleagues demonstrate how to spot 'publication bias' in the reporting of clinical trials which potentially form the basis of Government and NHS health policies.
AVEO Pharmaceuticals, Inc., today announced data from the final analysis of its Phase 2 randomized discontinuation trial evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with advanced renal cell carcinoma.
› Verified 9 days ago
Julia Fitzpatrick, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-355-9703 | |
Charlie Jim Moore, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2481 I 40 W, Amarillo, TX 79109 Phone: 806-358-2205 Fax: 806-463-2907 | |
William A Sansing, OPTOMETRIST Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2700 Paramount Blvd, Amarillo, TX 79109 Phone: 806-355-9536 Fax: 806-353-5572 | |
Dr. Candace E Lipshy, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5311 W 9th Ave, Amarillo, TX 79106 Phone: 806-359-3937 Fax: 806-359-8124 | |
Dr. William Robert Chafin Iii, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2303 S Georgia St, Amarillo, TX 79109 Phone: 806-359-3956 Fax: 806-355-6907 | |
Kayci Houlette, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3635 S Soncy Rd, Amarillo, TX 79119 Phone: 806-356-6868 Fax: 806-351-0120 | |
Medical Center Eye Associates, P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 1900 S Coulter Drive, Suite I, Amarillo, TX 79106 Phone: 806-355-9411 Fax: 806-322-3451 |